Jakob Passweg
Universität Basel
H-index: 107
Europe-Switzerland
Top articles of Jakob Passweg
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human … | Cancer | Justin Loke Myriam Labopin Charles Craddock Gérard Socié Tobias Gedde‐Dahl | 2024/4/6 |
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | Jakob E Brune Michael Dickenmann Daniel Sidler Laura N Walti Déla Golshayan | 2024/2/15 |
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation | Bone Marrow Transplantation | Alexandros Spyridonidis Myriam Labopin Tobias Gedde-Dahl Arnold Ganser Matthias Stelljes | 2024/2 |
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells | Blood Advances | Shivam Rai Yang Zhang Elodie Grockowiak Quentin Kimmerlin Nils Hansen | 2024/3/12 |
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the … | British Journal of Haematology | Francesco Onida Luuk Gras Junran Ge Linda Koster Rose‐Marie Hamladji | 2024/4/5 |
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic … | Blood | Maria Queralt Salas Dirk-Jan Eikema Sr Linda Koster Johan Maertens Jakob Passweg Sr | 2023/11/28 |
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … | Olaf Penack Monia Marchetti Tapani Ruutu Mahmoud Aljurf Andrea Bacigalupo | 2020/2/1 | |
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT | Kanwaldeep Mallhi Lawrence G Lum Kirk R Schultz Maxim Yankelevich | 2015/2/1 | |
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood … | Leukemia & Lymphoma | Sun-Hye Ko Jung-Hee Lee Je-Hwan Lee Han-Seung Park Eun-Ji Choi | 2018/8/3 |
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) | Bone Marrow Transplantation | Christian Niederwieser Simona Iacobelli Georg-Nikolaus Franke Linda Koster Marleen van Os | 2024/4/25 |
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry | Journal of Allergy and Clinical Immunology | Eyal Grunebaum Danielle E Arnold Brent Logan Suhag Parikh Rebecca A Marsh | 2024/1/28 |
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT | Transplantation and Cellular Therapy | Khalil Ben Hassine Claire Seydoux Sonia Khier Youssef Daali Michael Medinger | 2024/3/1 |
Post-Transplant Cyclophosphamide, Tacrolimus (TAC) or Cyclosporine a and Mycophenolate Mofetil Versus Anti-Thymocyte Globulin, TAC, Methotrexate Combinations As Graft-versus … | Arnon Nagler Myriam Labopin Thomas Schroeder Rose-Marie Hamladji Laimonas Griskevicius | 2024/2/1 | |
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT | Acta Haematologica | Thomas Weber Sunday Ocheni Mascha Binder Sebastian Theurich Christof Scheid | 2013/4/1 |
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT | Blood | Juan Montoro Dirk-Jan Eikema Joe Tuffnell Victoria Potter Krzysztof Kalwak | 2024/4/23 |
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan | Bone Marrow Transplantation | Claire Seydoux Chakradhara Rao Satyanarayana Uppugunduri Michael Medinger Tiago Nava Joerg Halter | 2024 |
Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation | Laura Infanti Gerda Leitner Morten Moe Vildana Pehlic Marco Cattaneo | 2024/3/19 | |
Post-transplant inflammatory bowel disease associated with donor-derived TIM-3 deficiency | Journal of Clinical Immunology | Adrian Baldrich Dominic Althaus Thomas Menter Julia R Hirsiger Julius Köppen | 2024/3 |
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal … | Bone Marrow Transplantation | Silvio Ragozzino Nicolas J Mueller Dionysios Neofytos Jakob Passweg Antonia Müller | 2024/2 |
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as … | Bone Marrow Transplantation | Arnon Nagler Myriam Labopin Ryszard Swoboda Thomas Schroeder Rose-Marie Hamladji | 2024/4/13 |
